The medical threat of biological weapons

Critical Reviews in Microbiology

Volumn 24, Issue 3, 1998, Pages 157-168

  Atlas, Ronald M ^a  

^a UNIVERSITY OF LOUISVILLE   (United States)

Author keywords

Biological warfare; Biological weapons; Bioterrorism

Indexed keywords

BOTULINUM TOXIN;

ANTHRAX; ARMY; BACILLUS ANTHRACIS; BIOLOGICAL WARFARE; INFECTION RISK; MICROBIAL GROWTH; PRIORITY JOURNAL; REVIEW;

BACTERIAL INFECTIONS; BIOLOGICAL WARFARE; HUMANS; PUBLIC HEALTH; TOXEMIA; VIRUS DISEASES;

EID: 0031660062     PISSN: 1040841X     EISSN: None     Source Type: Journal    
DOI: 10.1080/10408419891294280     Document Type: Review

References (17)

1. Danzig R. and Berkowsky, P. B., Why should we be concerned about biological warfare?, JAMA, 278, (5), 431, 1997.
2. Steinbruner, J. D., Biological weapons: A plague upon all houses, Foreign Policy, Winter, 85-96, 1997-98.
3. Christopher, G., Cieslak, T. J., Pavlin,J. A., and Eitzen, E. M., Biological warfare: A historical perspective, JAMA, 278, 5, 416.
4. Török, T. J., Tauxe, R. V., Wise, R. P., Livengood, J. R., Sokolow, R., Mauvais, S., Birkness, K. A., Skeels, M. R., Horan, J. M., and Foster, L. R., A large community outbreak of Salmonellosis caused by intentional contamination of restaurant salad bars, JAMA, 278, (5), 389-395, 1997.
5. Crowell, R., The emerging threat environment, In: Potomac Institute for Policy Studies, Conference on Countering Biological Terrorism: Strategic Firepower in the Hands of Many?, Proceedings Report, August 12-13, 1997, Arlington, VA.
6. Compton J. A. F., Military Chemicals and Biological Agents, Telford Press, Caldwell, N.J., 1987.
7. Meselson, M., Guillemin, J., Hugh-Jones, M., Langmuir, A., Popova, I., Shelokov, A., and Yampolskaya, O., The Sverdlovsk anthrax outbreak of 1979, Science, 266, 1202-1208, 1994.
8. Piles, J. C., Malone, J. D., Eitzen, E. M., and, Friedlander, A.M., Anthrax as a potential biological warfare agent, Arch. Intern. Med., 158, 433, 1998.
9. Friedlander, A. M., Welkos, S. L., and Pitt, M. L. M., Postexposure prophylaxis against experimental inhalation anthrax, J. Infect. Dis., 167, 1239-1242, 1993.
10. Henderson, D. A., Bioterrorism as a health threat, Emerging Infectious Diseases, 4, 488-492,. 1998.
11. Abilek, K., Terrorist and intelligence operations: Potential impact on the U.S. economy, Statement before the Joint Economic Committee, United States Congress, Wednesday, May 20, 1998.
12. Bermudez, J. S., Jr., Case study 5: North Korea, In: The Deterrence Series, Chemical and Biological Arms Control Institute, Washington, D.C., 1998.
13. Geissler, E., Duel-threat agents: the hostile use of pathogens and its regulation, In: The Diagnostic Challenge, Knowledge for Health, Infectious Diseases, Fischer E. P. and Klose, S., Eds., Piper Publishing, München, Zürich, 270-271.
14. Pomerantsev, A. P., Staritsin, N. A., Mockov, U. V., and Marinin, L. I., Expression of cereolysine AB genes in Bacillus anthracis vaccine strain ensures protection against experimental hemolytic anthrax infection, Vaccine, 15, 17/18, 1997.
15. Lewis, R., Bioweapons research proliferates, The Scientist, April 27, 6, 1998.
16. Miller, J. and Broad, W. J., U.S. ready for germ terror? Test says no, Sacramento Bee, A1, April 26, 1998.
17. Franz, D. R., Jahrling, P. B., Friedlander, A. M., McClain, D. J., Hoover, D. L., Bryne, W. R., Pavlin, J. A., Christopher, G. W., and Eitzen, E. M., Clinical recognition and management of patients exposed to biological warfare agents, JAMA, 278, 5, 400, 1997.